CN103980487A - Preparation method for degradable porous polyethylene glycol - Google Patents
Preparation method for degradable porous polyethylene glycol Download PDFInfo
- Publication number
- CN103980487A CN103980487A CN201410187588.6A CN201410187588A CN103980487A CN 103980487 A CN103980487 A CN 103980487A CN 201410187588 A CN201410187588 A CN 201410187588A CN 103980487 A CN103980487 A CN 103980487A
- Authority
- CN
- China
- Prior art keywords
- polyoxyethylene glycol
- block copolymer
- polyethylene glycol
- star
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001223 polyethylene glycol Polymers 0.000 title claims abstract description 19
- 239000002202 Polyethylene glycol Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- -1 poly(gamma-benzyl-L-glutamate) Polymers 0.000 claims abstract description 42
- 239000000463 material Substances 0.000 claims abstract description 39
- 229920001400 block copolymer Polymers 0.000 claims abstract description 23
- 239000011148 porous material Substances 0.000 claims abstract description 11
- 108010020346 Polyglutamic Acid Proteins 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 10
- 229920002643 polyglutamic acid Polymers 0.000 claims abstract description 10
- 238000007151 ring opening polymerisation reaction Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 230000007062 hydrolysis Effects 0.000 claims abstract description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 3
- 239000003999 initiator Substances 0.000 claims abstract 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 44
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 22
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 22
- 229920001577 copolymer Polymers 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- DHQUQYYPAWHGAR-UHFFFAOYSA-N dibenzyl 2-aminopentanedioate Chemical compound C=1C=CC=CC=1COC(=O)C(N)CCC(=O)OCC1=CC=CC=C1 DHQUQYYPAWHGAR-UHFFFAOYSA-N 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 238000009736 wetting Methods 0.000 claims description 5
- 239000002861 polymer material Substances 0.000 claims description 4
- 238000006555 catalytic reaction Methods 0.000 claims description 3
- 238000006116 polymerization reaction Methods 0.000 claims description 3
- 239000000178 monomer Substances 0.000 claims description 2
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 claims 2
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 150000003141 primary amines Chemical class 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 abstract description 6
- 238000001727 in vivo Methods 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 2
- 239000007943 implant Substances 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 229920000835 poly(gamma-benzyl-L-glutamate) polymer Polymers 0.000 abstract 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 238000007142 ring opening reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- 239000004626 polylactic acid Substances 0.000 description 11
- 238000006731 degradation reaction Methods 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 238000005191 phase separation Methods 0.000 description 8
- 230000015556 catabolic process Effects 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 101100021395 Arabidopsis thaliana LIP1 gene Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 3
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 101000651178 Homo sapiens Striated muscle preferentially expressed protein kinase Proteins 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 102100027659 Striated muscle preferentially expressed protein kinase Human genes 0.000 description 2
- 239000003519 biomedical and dental material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 229940068984 polyvinyl alcohol Drugs 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000004736 wide-angle X-ray diffraction Methods 0.000 description 2
- 0 *CC(C*N)O* Chemical compound *CC(C*N)O* 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 238000000235 small-angle X-ray scattering Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Abstract
The invention discloses a preparation method for degradable porous polyethylene glycol. The preparation method comprises the following steps: with oxirane as a raw material, synthesizing three-arm polyethylene glycol by using an alkaline ring opening process; preparing a macro-molecular initiator; carrying out ring-opening polymerization with gamma-benzyl-L-glutamate-carboxylic acid anhydride (NCA) so as to obtain a star-block copolymer with PEG as a core and poly(gamma-benzyl-L-glutamate) as an arm; removing a benzyl protective group in poly(gamma-benzyl-L-glutamate) through hydrolysis so as to obtain a star polyethylene glycol/polyglutamic acid block copolymer; and adding low-molecular-weight polyglutamic acid and dissolving the block copolymer with water by using amphipathicity of the block copolymer so as to form a nanometer porous material. The block copolymer has a hexagonal prism-like structure, the continuous phase of the block copolymer is polyethylene glycol, and the material has nanometer holes. The material has nanometer holes, overcomes the disadvantage of poor processability of a traditional linear polyethylene glycol material, exerts no toxic and side effects and can be used as a drug carrier material, a medical implant material and a material for a part of an in-vivo continuous dosing apparatus.
Description
Technical field
The present invention relates to a kind of degradable poly ethylene glycol material, particularly relate to a kind of preparation method with nanometer level microporous block macromolecular material.Belong to polymer chemistry and technical field of polymer.
Background technology
Poly(lactic acid) (Polylactic acid, PLA) be that a new generation of developing rapidly the nineties in 20th century can degradable macromolecular material, it has good biocompatibility, class bio-medical material and environment-friendly materials of food and drug administration (Food and Drug Adiministration, FDA) approval.From the sixties in 20th century, scientific worker starts to pay close attention to the degradation property of poly-lactic acid material, and first using poly-lactic acid material as degradable operation stitching wire material.1966, (the Kricheldorf H. R. such as Kulkarni
chemospherein 2001,43,49-54., propose first: low-molecular-weight PLA can degradation in vivo, and final meta-bolites is CO
2and H
2o, harmless, environmentally safe.Simultaneously, by the research of poly(lactic acid) vivo degradation process is found, the intermediate product lactic acid of degraded is the product of eubolism in body, can not accumulate in vivo, therefore PLA can not produce detrimentally affect to organism after degrading in vivo, has caused thus and has usingd the beginning of this class material as bio-medical material.In recent years, it in medicine sustained and controlled release system, has more and more received the concern of scientists as pharmaceutical carrier.
But common line style poly(lactic acid) (Linear polylactic acid, LPLA) there are some shortcomings, for example its solution and bulk viscosity are higher, degree of crystallinity is large, material fragility is high, thermostability is low and low degradation speed, limited to a certain extent it in the widespread use in the fields such as medical, agricultural and packing, particularly at the application aspect Thermosensitive Material Used for Controlled Releasing of Medicine (Wang L., Dong C. M.
j. Polym. Sci. Part A:Polym. Chem.2006,44 (7), 2226-2236.).Star-like poly(lactic acid) (Star-shaped polylactic acids, SPLA) there is the short and molecular weight advantages of higher of side chain, its solution and bulk viscosity are more much lower than same molecular amount LPLA, mobility and solubility property improve, and its degradation speed is but fast than same molecular amount LPLA, thermostability is higher, is conducive to its processed and applied in the bio-medical materials such as medicament slow release.
No matter although line style or star-like poly-lactic acid material have been widely used in Thermosensitive Material Used for Controlled Releasing of Medicine and tissue engineering material aspect, but the restriction due to himself hydrophobic structure, also part comes with some shortcomings, for example its wetting ability is not good, degradation rate is slower, degradation cycle is difficult to regulation and control, and implant inner posterior quadrant easily adheres to material surface etc.Scientists has been carried out the research of the modification of configuration aspects to PLA material for these problems.In order to increase the wetting ability of PLA, common material modified have polyoxyethylene glycol (Polyethylene glycol, PEG) (Moffatt S., Cristiano R.
j. Int. J. Pharm.2006,317,10-13.), polyvinyl alcohol (Poly vinyl alcohol, PVA), dextran (dextran), chitosan and polypeptide (polypeptide) etc.Because polypeptide (also referred to as polyamino acid) is the biodegradable polymer of a class, have low toxicity, good biocompatibility, biodegradable, easily by body, absorbed and the advantage such as metabolism, Amino Acid Unit structure can be selected, hydrophilicity and hydrophobicity is adjustable, started to be applied in the study on the modification of poly(lactic acid), but only had seldom report.
On the other hand, multiporous biological degradable material is the brand-new material system that development in recent years is got up, and is a kind of material with network structure consisting of mutual perforation or blind hole hole, and the border of hole or surface consist of pillar or flat board.It has regularly arranged and big or small adjustable pore passage structure, relative density is low, specific tenacity is high, porosity and surface-area large, perviousness and excellent adsorption and good biocompatibility, the features such as environmental friendliness, are all with a wide range of applications with fields such as separated, nanomaterial assembly, biological chemistry, molecular recognition and pharmaceutical carriers in bulky molecular catalysis, absorption.By us, to the consulting of documents and materials, also there is no so far that a kind of poly-lactic acid material has that processing characteristics is high simultaneously, a feature such as wetting ability, good biodegradability, nanometer level microporous, high Drug loading capacity.
Summary of the invention
The object of the invention is to set up a kind of preparation method of degradable multiporous polyoxyethylene glycol, this polymer materials has the following advantages: good processability, wetting ability, good biodegradability, nanometer level microporous, high Drug loading capacity.
This polyoxyethylene glycol material is a kind of star-shaped polyethylene glycol/polypeptide segmented copolymer; Take oxyethane as raw material, utilize alkaline process open loop method to synthesize three arm polyoxyethylene glycol; Prepare macromole evocating agent; Carry out ring-opening polymerization with benzyl glutamate carboxylic acid anhydride (NCA) and obtain take the star block copolymer that PEG is arm as core poly benzyl glutamate; By hydrolysis, slough the benzyl protecting group in poly benzyl glutamate, obtain star-shaped polyethylene glycol/polyglutamic acid block copolymer; Add lower molecular weight polyglutamic acid, utilize the amphiphilic water of segmented copolymer to be dissolved, form nanoscale porous material.
The technology of preparing scheme of porous polyoxyethylene glycol material is as follows:
1) star-shaped polyethylene glycol is synthetic
2) macromole evocating agent is synthetic
3) preparation of star block copolymer
4) star block copolymer protective reaction
5) preparation process of polyglycol porous material as shown in Figure 3
By above technical scheme, tool of the present invention has the following advantages: 1) degradable multiporous polyoxyethylene glycol has nano micropore structure capable;
2) degradable multiporous polyoxyethylene glycol has hexagonal columnar structure;
3) degradable multiporous polyoxyethylene glycol has high drug loading amount, and good biocompatibility;
4) degradable multiporous polyoxyethylene glycol has pharmaceutical carrier function and discharges pharmic function, can effectively reduce medicine normal tissue organ toxic side effect.
Accompanying drawing explanation
Fig. 1 is the vesicular structure schematic diagram of this polymer materials;
Fig. 2 is the electron photomicrograph (not deprotection) of this polymer materials;
Fig. 3 is the preparation process schematic diagram of polyglycol porous material.
Embodiment
Provide embodiment below so that the present invention is specifically described; but it is worthy of note that following examples are only used to further illustrate the present invention; can not be interpreted as limiting the scope of the invention, some nonessential improvement that the person skilled in the art in this field makes the present invention according to the invention described above content and adjustment still belong to protection scope of the present invention.
Embodiment 1:
1. prepare star block copolymer
Take oxyethane as raw material; utilize classical subtraction open loop method to synthesize three arms or multi-arm star-shaped polyethylene glycol; existence due to the hydroxyl of polymer ends; can adopt the glycine of amino Boc-radical protection; under the catalysis of DCC/HOBt, react with SPEG and generate SPEG derivative; in trifluoracetic acid/dichloromethane solution, carry out the amino de-Boc protection of above-mentioned product, obtained the star-like macromole evocating agent SPEG-NH of end amido functional group
2.Macromole evocating agent and benzyl glutamate carboxylic acid anhydride (NCA) are carried out to ring-opening polymerization by a certain percentage, the star block copolymer that to obtain take PEG be arm as core poly benzyl glutamate.Finally, adopt HBr, AcOH, trifluoroacetic acid mixed solution that benzyl protecting group is hydrolyzed, finally obtain star-shaped polyethylene glycol/polyglutamic acid block copolymer.
2. the sign of star block copolymer material self-assembled structures and performance
The chemical structure of polymkeric substance and shape characteristic are the bases of the every character of Study Polymer Melts.This problem intends utilizing gel permeation chromatography (GPC), Fourier transform infrared spectroscopy (FTIR) and nucleus magnetic resonance (NMR) method detect chemical structure and the polymerization degree of polymkeric substance, utilize thermogravimetric analyzer (TGA) to study the thermal characteristics of polymkeric substance, the transformation mutually, the liquid crystal behavior that use differential scanning calorimeter (DSC) research segmented copolymer, utilize one dimension, two-dimentional wide-angle x-ray diffraction instrument (WAXD) to determine the phase structure of each segment in segmented copolymer.The star block copolymer proposing in this problem more easily forms micro phase separation structure, can utilize atomic force microscope (AFM) and transmission electron microscope (TEM) to observe star block copolymer at the self-assembled structures of substrate surface, utilize little angle one dimension, two-dimentional x-ray diffractometer (SAXS) to study the micro phase separation structure of star block copolymer.
3. the preparation of porous material
Obtain after required polyoxyethylene glycol/polyglutamic acid star block copolymer, we will observe its body self-assembly behavior, mainly study its micro phase separation structure.Because the body microphase-separated self-assembled structures of segmented copolymer is relevant with the relative proportion that forms component, by the impacts of factor on the phase of micro phase separation structure and size such as content, molecular weight of research block component, we can determine may be applicable segmented copolymer to carry out aftertreatment.Particularly for the segmented copolymer that forms (six sides) column phase or co-continuous double helix phase, when material forms nano pore, and micro phase separation structure is arranged when even, material is higher for the release efficiency of medicine, during as embedded material and the contact area of body fluid increase, be conducive to improve the degradation speed of material.We as the impact on material micro phase separation structure such as solvent species, solvent evaporates speed, make the PGA block in polymkeric substance outside form column or double-spiral structure to obtain top condition research material preparation condition.
The synthetic PEG-b-PGA star block copolymer obtaining in a certain amount of lower molecular weight PGA homopolymer and above-mentioned route is carried out to blend, can obtain the hexagonal columnar phase micro phase separation structure that we need, phase structure can be by confirmations such as low-angle scattering of X-rays and high-resolution electron microscopes.The impact of composition etc. by research blend on the phase of micro phase separation structure and size, we can select suitable blend to carry out aftertreatment.On the other hand, if multipolymer forms co-continuous double helix phase, also may be used as porous material.Then we,, by having the film water treatment of column phase or co-continuous double helix phase structure, dissolve PGA homopolymer, just obtain the modified porous material of star-shaped polyethylene glycol containing hydrophilic nano duct, the carrier of useful as drug model compound.
4. porous star block copolymer is as the research of pharmaceutical carrier
This experiment is intended by existence form and the concentration of steady-state fluorescence spectral characterization and mensuration pyrene, with prove this based block copolymer whether can be in water solution system stable micro-molecular compound, and then discharge in EPC liposome, thereby explore this type of macromolecular material as the potential application of pharmaceutical carrier from the complex body of high-molecular block copolymer-pyrene.Main employing steady-state fluorescence spectroscopic analysis: the spectrum of all samples all records by right angle light path in 4 mL cuvettes.The spectrum of solid-state pyrene crystal is measured by solid support.While doing fluorescence emission spectrum mensuration, emission spectrum wavelength region is 350～650 nm, and excitation wavelength is 336 nm.Excitation spectrum records at emission wavelength 374 nm and 470 nm that represent pyrene monomer and excimer transmitting respectively.All scanning exciting light slits are made as 5 nm, and utilizing emitted light slit is made as 2.5 nm, and PMT voltage is all made as 400 volts, and sweep velocity is 240 nm/min, and spectrum correction is all made as opens to eliminate the wavelength dependency of grating and monitor response.Each Sample Scan is averaged for three times.Be determined at 25
ounder C, carry out.
Finally it should be noted that, above embodiment is only unrestricted in order to technical scheme of the present invention to be described, although the present invention is had been described in detail with reference to preferred embodiment, those of ordinary skill in the art should understand, can a minute technical scheme for invention be modified or be replaced on an equal basis, and not departing from the spirit and scope of technical solution of the present invention, it all should be encompassed in the middle of claim scope of the present invention.
Claims (7)
1. a degradable multiporous polyoxyethylene glycol, its constitutional features is: described macromolecular material is the star-like type multipolymer being formed by hydrophobicity polyoxyethylene glycol segment and the coupling of wetting ability polyglutamic acid segment.
2. a method of preparing degradable multiporous polyoxyethylene glycol claimed in claim 1 is carried out as follows:
1) take L-rac-Lactide as raw material, utilize stannous octoate catalysis open loop method to synthesize three arm polyoxyethylene glycol;
2) prepare macromole evocating agent;
3) carry out ring-opening polymerization with benzyl glutamate carboxylic acid anhydride and obtain take the star block copolymer that polyoxyethylene glycol is arm as core poly benzyl glutamate;
4) by hydrolysis, slough the benzyl protecting group in poly benzyl glutamate, obtain star-shaped polyethylene glycol/polyglutamic acid block copolymer;
5) add lower molecular weight polyglutamic acid, utilize the amphiphilic water of segmented copolymer to be dissolved, form nanoscale porous material.
3. the preparation method of a kind of degradable multiporous polyoxyethylene glycol according to claim 2, is characterized in that the catalyzer that in aforesaid method, star-type polymer that step 1) is closed is used is stannous octoate.
4. the preparation method of a kind of degradable multiporous polyoxyethylene glycol according to claim 2, is further characterized in that the polymerization single polymerization monomer that in aforesaid method, step 3) is used is benzyl glutamate carboxylic acid anhydride.
5. the preparation method of a kind of degradable multiporous polyoxyethylene glycol according to claim 2, is further characterized in that in the ring-opening polymerization that in aforesaid method, step 3) is carried out and uses primary amine to carry out polyreaction as initiator.
6. a kind of degradable multiporous polyoxyethylene glycol according to claim 2, is further characterized in that: this macromolecular material is the formed porous material of polyoxyethylene glycol and polyglutamic acid.
7. a kind of degradable multiporous polyoxyethylene glycol according to claim 2, is further characterized in that: described porous polymer materials has hexagonal columnar structure clearly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410187588.6A CN103980487A (en) | 2014-05-06 | 2014-05-06 | Preparation method for degradable porous polyethylene glycol |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410187588.6A CN103980487A (en) | 2014-05-06 | 2014-05-06 | Preparation method for degradable porous polyethylene glycol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103980487A true CN103980487A (en) | 2014-08-13 |
Family
ID=51272671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410187588.6A Pending CN103980487A (en) | 2014-05-06 | 2014-05-06 | Preparation method for degradable porous polyethylene glycol |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103980487A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105884917A (en) * | 2016-05-20 | 2016-08-24 | 江南大学 | Straight-chain dextrin-based lipidosome and preparation method thereof |
| CN111808293A (en) * | 2019-04-11 | 2020-10-23 | 九度(上海)化学有限公司 | Polyhydroxy polyester carboxylic acid polymer for preparing solvent type thermal foaming ink |
| CN112263547A (en) * | 2020-11-26 | 2021-01-26 | 深圳大学 | A kind of multifunctional nano-drug carrier and its preparation method and drug-carrying composition |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06107565A (en) * | 1992-08-14 | 1994-04-19 | Res Dev Corp Of Japan | Physical adsorption type polymeric micelle drug |
| US20060224095A1 (en) * | 2005-04-05 | 2006-10-05 | University Of New Hampshire | Biocompatible polymeric vesicles self assembled from triblock copolymers |
| CN102911368A (en) * | 2012-11-16 | 2013-02-06 | 苏州大学 | Amphiphilic triblock copolymer with acid sensitivity and preparation method and application thereof |
| CN102942695A (en) * | 2012-12-04 | 2013-02-27 | 中国科学院长春应用化学研究所 | Polymer, glucose nano gel, glucose nano gel composition and preparation method thereof |
| CN102964593A (en) * | 2012-12-17 | 2013-03-13 | 中国科学院长春应用化学研究所 | Block polymer, preparation method thereof and electrically active hydrogel |
| WO2013047946A1 (en) * | 2011-09-29 | 2013-04-04 | 중앙대학교 산학협력단 | Bab-type tri-block copolymer comprising polylactic acid (a) and polyethylene glycol (b), method for producing same, and drug delivery system using same |
| CN103113579A (en) * | 2013-02-21 | 2013-05-22 | 华东理工大学 | Polyglutamic acid derivative as well as hydrogel and preparation method of polyglutamic acid derivative |
| CN103483582A (en) * | 2013-08-22 | 2014-01-01 | 山东大学 | Biodegradable polymer vesicle with pH responsiveness, and preparation method and application thereof |
-
2014
- 2014-05-06 CN CN201410187588.6A patent/CN103980487A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06107565A (en) * | 1992-08-14 | 1994-04-19 | Res Dev Corp Of Japan | Physical adsorption type polymeric micelle drug |
| US20060224095A1 (en) * | 2005-04-05 | 2006-10-05 | University Of New Hampshire | Biocompatible polymeric vesicles self assembled from triblock copolymers |
| WO2013047946A1 (en) * | 2011-09-29 | 2013-04-04 | 중앙대학교 산학협력단 | Bab-type tri-block copolymer comprising polylactic acid (a) and polyethylene glycol (b), method for producing same, and drug delivery system using same |
| CN102911368A (en) * | 2012-11-16 | 2013-02-06 | 苏州大学 | Amphiphilic triblock copolymer with acid sensitivity and preparation method and application thereof |
| CN102942695A (en) * | 2012-12-04 | 2013-02-27 | 中国科学院长春应用化学研究所 | Polymer, glucose nano gel, glucose nano gel composition and preparation method thereof |
| CN102964593A (en) * | 2012-12-17 | 2013-03-13 | 中国科学院长春应用化学研究所 | Block polymer, preparation method thereof and electrically active hydrogel |
| CN103113579A (en) * | 2013-02-21 | 2013-05-22 | 华东理工大学 | Polyglutamic acid derivative as well as hydrogel and preparation method of polyglutamic acid derivative |
| CN103483582A (en) * | 2013-08-22 | 2014-01-01 | 山东大学 | Biodegradable polymer vesicle with pH responsiveness, and preparation method and application thereof |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105884917A (en) * | 2016-05-20 | 2016-08-24 | 江南大学 | Straight-chain dextrin-based lipidosome and preparation method thereof |
| CN105884917B (en) * | 2016-05-20 | 2018-05-25 | 江南大学 | A kind of linear dextrin base liposome and preparation method thereof |
| CN111808293A (en) * | 2019-04-11 | 2020-10-23 | 九度(上海)化学有限公司 | Polyhydroxy polyester carboxylic acid polymer for preparing solvent type thermal foaming ink |
| CN111808293B (en) * | 2019-04-11 | 2022-04-08 | 九度(上海)化学有限公司 | Polyhydroxy polyester carboxylic acid polymer for preparing solvent type thermal foaming ink |
| CN112263547A (en) * | 2020-11-26 | 2021-01-26 | 深圳大学 | A kind of multifunctional nano-drug carrier and its preparation method and drug-carrying composition |
| CN112263547B (en) * | 2020-11-26 | 2022-12-20 | 深圳大学 | A kind of multifunctional nano drug carrier and its preparation method and drug-loaded composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ding et al. | Preparation of photo-cross-linked pH-responsive polypeptide nanogels as potential carriers for controlled drug delivery | |
| Naeini et al. | Poly (citric acid)-block-poly (ethylene glycol) copolymers—new biocompatible hybrid materials for nanomedicine | |
| JP2003055460A (en) | Amphipathic biodegradable block copolymer having polyethyleneimine as hydrophilic block and polyester based polymer as hydrophobic block and self-associated polymer aggregate formed therefrom in aqueous environment | |
| Adami et al. | PLA–PEG copolymers micronization by supercritical assisted atomization | |
| CN103992475A (en) | Biocompatible degradable porous polyethylene glycol material | |
| Lambermont-Thijs et al. | Selective partial hydrolysis of amphiphilic copoly (2-oxazoline) s as basis for temperature and pH responsive micelles | |
| Martel-Estrada et al. | Synthesis and thermo-physical properties of chitosan/poly (dl-lactide-co-glycolide) composites prepared by thermally induced phase separation | |
| Yuan et al. | PEG-detachable and acid-labile cross-linked micelles based on orthoester linked graftcopolymer for paclitaxel release | |
| CN103980487A (en) | Preparation method for degradable porous polyethylene glycol | |
| Liu et al. | Preparation of a polysaccharide–polyester diblock copolymer and its micellar characteristics | |
| CN104072707A (en) | Method for preparing star-shaped block copolymer porous drug carrier | |
| Yang et al. | Self-assembling of biocompatible BAB amphiphilic triblock copolymers PLL (Z)–PEG–PLL (Z) in aqueous medium | |
| CN104086722A (en) | Method for preparing biological porous material | |
| CN104059207A (en) | Acrylic acid and polyactic acid (PAA) contained functional polymer material | |
| Han et al. | Electrospinning of methoxy poly (ethylene glycol)-grafted chitosan and poly (ethylene oxide) blend aqueous solution | |
| CN102391446A (en) | Method for preparing biocompatible polymer nano-vesicle in pure water | |
| CN104072701A (en) | Method for synthesizing ABC multiblock copolymer drug polymer | |
| CN104448807A (en) | Degradable porous poly lactic acid preparation method | |
| CN104086726A (en) | Polylactic acid (PLA) star-shaped diblock-copolymer medicinal functional material | |
| CN104059206A (en) | Preparation method of multifunctional medicinal polylactic acid (PLA) derivative ABC triblock polymer | |
| CN104086723A (en) | Multiblock multifunctional medicinal macromolecular material | |
| CN104109240A (en) | Preparation method of porous polyethylene glycol (PEG) capable of serving as drug carrier | |
| CN104109255A (en) | Novel medical polyethylene glycol (PEG) functional material | |
| CN104086769A (en) | Novel medical functional polyethylene glycol material | |
| CN104109239A (en) | Medical microporous polyethylene glycol (PEG) material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140813 |